SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Claude Code creator's prompting formula: Say what you want and let AI figure out the rest

U.S. Army deploys Elbit's Iron Fist defense system against missiles and drones

Teva gets FDA green light for second long-acting schizophrenia drug

What Daniela Amodei says separates successful startup founders from the rest

Buzz

Most popular

Daily

Weekly

1

Nvidia hits record $5.65 trillion as SpaceX seeks $40 billion to buy its AI chips

2

Israel loses $1 billion Apache deal after failing to find $288 million in funding

3

Nikesh Arora sees 40 companies racing to secure AI agents. At least 20 are Israeli

4

Oracle is cutting jobs worldwide. In Israel, it is still hiring

5

Israeli startup raises $5 million to rethink one of surgery's most invasive procedures

Clinical Trials

5 stories about Clinical Trials

בניין חברת טבע כפר סבא

Teva moves closer to a drug for celiac disease with positive Phase 2 results

02.09.26|Sophie Shulman

The company's TEV-408 antibody met its primary endpoint in a 50-patient trial and reduced intestinal damage, inflammation and gastrointestinal symptoms. Teva is also advancing the treatment for vitiligo, potentially expanding the commercial opportunity for the same drug.

rewalk רובוטיקה שלד חיצוני

ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit

04.04.18|Asaf Shalev

After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators

Company that Develops Injectable Bone Grafts Expands Clinical Trial

12.03.18|Dror Reich

Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure

Bonus Biogroup Says First Lab-Grown Leg Bone Transplanted in Patient

21.12.17|Lilach Baumer

The Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection

MeMed מכשיר לזיהוי זיהום ב דם

Automated Medical Diagnosis Startup Raises $30 Million

19.09.17|Omer Kabir

Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense